Journal
Spotlights
Webinars
Channels
Analytics
Manufacturing
Vectors
Regulatory
Supply Chain
Translational Research & Clinical Development
Business and Finance
Reports
Regulatory Insights
Clinical Trends
Innovation Insights
Business Insights
Investor Insights
FastFacts
Media Kit
Media Kit
Editorial calendar
Sponsorship opportunities
Webinars
About
Submit your manuscript
Meet the team
Get in touch
Immuno-Oncology Insights
Login
Register
Update your profile
Logout
CELL & GENE THERAPY
INSIGHTS
Market access: evolving commercialization trends and strategies
Guest Editor:
Neil Palmer, President and Principal Consultant at PDCI Market Access
Neil Palmer
President and Principal Consultant at PDCI Market Access
August 2020
Download full spotlight
The heart of market access: opportunities and challenges for cell and gene therapy development for orphan and prevalent cardiovascular diseases
F Ali
23 September 2020
Commentary
Read more
Under construction: roadmaps for HTA, pricing and reimbursement of cell and gene therapies
N Palmer
3 September 2020
Foreword
Read more
Joint collaborations and future perspectives for gene therapies.
M Dabbous,
B Borissov,
C Dussart
et al.
3 September 2020
Commentary
Read more
How should health technology assessment of ATMPs evolve in Europe?
M Toumi
2 September 2020
Interview
Read more
From rare monogenic diseases to Parkinson’s: market access considerations for gene therapy across large and small indications
P Meswani
28 August 2020
Interview
Read more
Challenges and proposed solutions to value assessment and reimbursement of CAR-T therapies in Europe
C Hague,
M Price
28 August 2020
Expert Insight
Read more
HTA evolution in Canada: considerations for cell and gene therapy
S McGurn
26 August 2020
Interview
Read more
Bringing advanced therapies to the clinic: the Swedish National ATMP Consortium (CAMP/SWElife ATMP)
S Scheding,
H Main,
P Blomberg
18 August 2020
Commentary
Read more
Challenges in the adoption of regenerative medicine therapies, meeting summary
M Chaddah,
S McMahon,
J Kusena
et al.
13 August 2020
Commentary
Read more
Innovative payments for innovative therapies: adopting value-based models in the regenerative medicines & advanced therapy sector
J Lambert
10 August 2020
Commentary
Read more
×
Please enter your email to register
Register